Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

The European Commission granted marketing authorisation for Eli Lilly and Company and Boehringer Ingelheim's insulin glargine product, indicated to treat diabetes in adults, adolescents and children aged 2 years and above.

10 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

Miriam Hospital receives grant from NIH to prevent spread of sexually transmitted HIV in women

The Miriam Hospital is part of a research collaboration that has received a $20 million grant from the National Institutes of Health (NIH) to develop an intravaginal ring (IVR) that can deliver powerful antiretroviral (ARV) drugs to prevent the spread of sexually transmitted HIV in women.

9 Sep 2014

Three Clemson startup companies receive $25,000 in seed money from USAP

Clemson University Research Foundation (CURF) announced that three Clemson startup companies have each received $25,000 in seed money from the University Sponsored Application Program (USAP) offered by SC Launch.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Porvair Sciences has published an informative 8-page brochure providing scientists with a background to Chromatin Immunoprecipitation (ChIP), an introduction to Chromatrap® ChIP assay technology and how Chromatrap® compares to traditional bead based methodologies.

From Chromatrap® - Porvair Sciences Ltd 4 Sep 2014

State highlights: Mass. health spending slows, but for how long?

Two years ago, Massachusetts set what was considered an ambitious goal: The state would not let that persistent monster, rising health care costs, increase faster than the economy as a whole.

4 Sep 2014

European GMP certification awarded to Ajinomoto Althea

Ajinomoto Althea, Inc. ("Althea"), a leading provider of biopharmaceutical contract development and manufacturing services announced today that it has officially received its European GMP certificate issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

3 Sep 2014

First Edition: September 3, 2014

Today's headlines include reports about how insurers and consumers are bracing for round two as the health law's online insurance marketplaces prepare for open enrollment season.

3 Sep 2014

New approach to turn diseased cells into unique manufacturing sites for treating muscular dystrophy

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing sites for molecules that can treat a form of muscular dystrophy.

3 Sep 2014

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products.

3 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Pfenex reports total revenue of $3.3 million for second quarter 2014

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014.

30 Aug 2014

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.

29 Aug 2014

H. D. Smith announces winners of annual Trading Partners of the Year award

H. D. Smith, among the nation's largest pharmaceutical wholesalers, today announced the winners of its annual Trading Partners of the Year award, honoring select pharmaceutical and health products manufacturers who collaborate actively to grow the industry and advance patient care.

28 Aug 2014

EMIT receives CE-Mark for HypothermX Intravenous Fluid and Blood Warming Devices

EMIT Corporation announced today that it has received CE-Mark for its HypothermX Intravenous Fluid and Blood Warming Devices with sterile fluid paths, allowing for sales expansion into the European and other OUS markets.

28 Aug 2014

TxCell announces five new patents for core technology and ASTrIA platform

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, today announces that five new patents for their technologies have been issued in the Unites States, Asia and Australia since the beginning of 2014.

27 Aug 2014

Actavis files ANDA for generic version of Neupro

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transdermal Film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr.

25 Aug 2014

Dr. John S. Sampalis nominated as finalist in the 2014 EY Entrepreneur Of The Year award

Dr. John S. Sampalis is founder and CEO of JSS Medical Research and one of the world's leading clinical epidemiologists. Dr. Sampalis is nominated as a finalist in this year's 2014 EY Entrepreneur Of The Year in the Québec Health Sciences category.

22 Aug 2014

Manufacturing News and Research

Further Reading

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

Kinex Pharmaceuticals acquires QuaDPharma

Miriam Hospital receives grant from NIH to prevent spread of sexually transmitted HIV in women

Three Clemson startup companies receive $25,000 in seed money from USAP

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

State highlights: Mass. health spending slows, but for how long?

European GMP certification awarded to Ajinomoto Althea

First Edition: September 3, 2014

New approach to turn diseased cells into unique manufacturing sites for treating muscular dystrophy

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Pfenex reports total revenue of $3.3 million for second quarter 2014

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

H. D. Smith announces winners of annual Trading Partners of the Year award

EMIT receives CE-Mark for HypothermX Intravenous Fluid and Blood Warming Devices

TxCell announces five new patents for core technology and ASTrIA platform

Actavis files ANDA for generic version of Neupro

Dr. John S. Sampalis nominated as finalist in the 2014 EY Entrepreneur Of The Year award

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®